Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells

Cancer Research

Volumn 58, Issue 2, 1998, Pages 310-314

  Khanna, Rajiv ^a   Busson, Pierre ^b   Burrows, Scott R ^a   Raffoux, Colette ^d   Moss, Denis J ^a   Nicholls, John M ^c   Cooper, Leanne ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; PROTEASOME; PROTEIN LMP2; PROTEIN LMP7; PROTEIN TAP2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ADULT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BURKITT LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; VIRUS EXPRESSION;

ADULT; AGED; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA; DNA PRIMERS; EPITOPES; FEMALE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031964512     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Den Otter, W. Immune surveillance and natural resistance: an evaluation. Cancer Immunol. Immunother., 21: 85-92, 1986.
2. Melief, C. J. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res., 58: 143-175, 1992.
3. Braciale, T. J., and Braciale, V. L. Antigen presentation: structural themes and functional variations. Immunol. Today, 12: 124-129, 1991.
4. Trowsdale, J., Hanson, I., Mockridge, I., Beck, S., Townsend, A., and Kelly, A. Sequences encoded in the class II region of the MHC related to the "ABC" super-family of transporters. Nature (Lond.), 348: 741-744, 1990.
5. Spies, T., Bresnahan, M., Bahram, S., Arnold, D., Blanck, G., and Mellins, E. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature (Lond.), 348: 744-747, 1990.
6. Rooney, C. M., Smith, C. A., Ng, C. Y. C., Loftin, S., Li, C., Krance, R. A., Brenner, M. K., and Heslop, H. E. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet, 345: 9-13, 1995.
7. Lewis, J. J., and Houghton, A. N. Definition of tumor antigens suitable for vaccine construction. Semin. Cancer Biol., 6: 321-327, 1995.
8. Pardoll, D. M. Cancer vaccines. Trends Pharmacol. Sci., 14: 202-208, 1993.
9. Busson, P., Ganem, G., Flores, P., Mugneret, F., Clausse, B., Caillou, B., Braham, K., Wakasugi, H., Lipinski, M., and Tursz, T. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer, 42: 599-606, 1988.
10. Moss, D. J., Misko, I. S., Burrows, S. R., Burman, K., McCarthy, R., and Sculley, T. B. Cytotoxic T-cell clones discriminate between A-and B-type Epstein-Barr virus transformants. Nature (Lond.), 331: 719-721, 1988.
11. Salter, R. D., and Cresswell, P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J., 5: 943-949, 1986.
12. Gavioli, R., Kurilla, M. G., de Campos-Lima, P. O., Wallace, L. E., Dolcetti, R., Murray, R. J., Rickinson, A. B., and Masucci, M. G. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol., 67: 1572-1578, 1993.
13. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K., and Mark, D. F. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science (Washington DC), 223: 1412-1414, 1984.
14. Wang, A., Lu, S. D., and Mark, D. F. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science (Lond.), 224: 1431-1433, 1984.
15. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E., and Moss, D. J. Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med., 176: 169-176, 1992.
16. Khanna, R., Jacob, C. A., Burrows, S. R., and Moss, D. J. Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection. J. Immunol. Methods, 164: 41-49, 1993.
17. Khanna, R., Jacob, C. A., Burrows, S. R., Kurilla, M. G., Kieff, E., Misko, I. S., and Moss, D. J. Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T-cells. Immunology, 74: 504-510, 1991.
18. Khanna, R., Burrows, S. R., Argaet, V., and Moss, D. J. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. Int. Immunol., 6: 639-645, 1994.
19. Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Croom Carter, D., Lee, S., Burrows, S. R., Moss, D. J., and Rickinson, A. B. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur. J. Immunol. 25: 1374-1384, 1995.
20. Fahraeus, R., Fu, H. L., Ernberg, I., Finke, J., Rowe, M., Klein, G., Falk, K., Nilsson, E., Yadav, M., Busson, P., Tursz, T., and Kallin, B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer, 42: 329-338, 1988.
21. Murray, N., and McMichael, A. Antigen presentation in virus infection. Curr. Opin. Immunol., 4: 401-407, 1992.